Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Improved overall survival in melanoma with combined dabrafenib and trametinib.

Improved overall survival in melanoma with combined dabrafenib and trametinib. N Engl J Med. 2015 Jan 01; 372(1):30-9.

View in: PubMed

© 2022 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.